Back to Agenda
Session 9 Track 1: Navigating Medical Communication Regulatory Compliance: Best Practices for Pharma MI
Session Chair(s)
Barbara Nardi, PharmD
Global Director - Medical Communications
Thermo Fisher Scientific, Brazil
In this session, we will delve into the complexities of medical communication regulatory compliance within the pharmaceutical industry. Participants will gain a comprehensive understanding of different regulatory frameworks and its implications for medical information (MI) practices. We will discuss common challenges faced by pharma companies and present best practices for ensuring compliance while maintaining effective and transparent communication.
Learning Objective : - Gain a comprehensive understanding of various regulatory frameworks governing medical communication and their implications for MI practices
- Discuss the common challenges faced by pharma companies in adhering to regulatory requirements and explore strategies to overcome
- Learn and implement best practices for ensuring regulatory compliance while maintaining effective and transparent communication
Speaker(s)
From Compliance to Confidence: Interupting EU Regulations to Strengthen MI Strategy
Natalia Sanchez Gandarillas, MPharm
EVERSANA, United Kingdom
Associate Director Med Affairs and Med Info
Have an account?